NCT00679926View on ClinicalTrials.gov

Kaletra and Viread in Antiretroviral Naïve Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
HIV Infections
Interventions
DRUG

Once daily

Four tablets of lopinavir/ritonavir and one tablet of tenofovir given once daily

Trial Locations (1)

74127

OSU Internal Medicine Specialty Clinic, Tulsa

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Oklahoma State University Center for Health Sciences

OTHER

NCT00679926 - Kaletra and Viread in Antiretroviral Naïve Patients | Biotech Hunter | Biotech Hunter